It is clinically-proven for long-term benefits.
Results from a 3-month clinical study show Petadolex can reduce occurrences by as much as 62% following 2 months of continuous use.
Petadolex contains a patented, standardized, and clinically studied extract of butterbur (Petasites hybridus). Its unique extraction method (for which the patent was granted) guarantees that it is free from harmful levels of potentially dangerous compounds known as pyrrolizidine alkaloids (PAs).
Take 1 softgel three times daily for the first four weeks. Thereafter, 1 softgel twice daily.
1 Softgel Amount/Serving DV
Purple Butterbur (Petasites hybridus) 50 mg
(Petadolex brand) Root Extract standardized to contain 7.5 mg petasins and to be free of harmful levels of pyrrolizidine alkaloids (PAs)
Daily Value (DV) not established.
medium chain triglycerides, gelatin, vegetable glycerin, water, and riboflavin color.
sugar, salt, yeast, wheat, gluten, corn, soy, dairy products, artificial flavoring or preservatives. All colors used are from natural sources.
Do not use if pregnant or nursing.
If taking prescription drugs, consult your healthcare practitioner prior to use.
Petadolex is a registered trademark of Weber Weber International GmbH Co.
Product of Germany.
Distributed by an FDA-registered Drug Establishment.